<?xml version="1.0" encoding="UTF-8"?><meta xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns="http://www.w3.org/1999/xhtml" xmlns:xi="http://www.w3.org/2001/XInclude" http-equiv="Content-Type" content="text/html; charset=utf-8" />
<style xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns:xi="http://www.w3.org/2001/XInclude" type="text/css">
   @media screen{
   .test-story-main legend{
   text-align:center;
   font-size:110%;
   font-weight:bold;
   }
   .test-story-main .nav-tabs{
   font-weight:bold;
   }
   .test-story-main .tds_obxGrpSpl{
   background:#B8B8B8;
   }
   .test-story-main maskByMediaType{
   display:table;
   }
   .test-story-main table tbody tr th{
   font-size:95%
   }
   .test-story-main table tbody tr td{
   font-size: 110%;
   }
   .test-story-main table tbody tr th{
   text-align:left;
   background:#C6DEFF;
   font-size:100%;
   }
   .test-story-main fieldset{
   text-align:center;
   }
   .test-story-main table{
   width:98%;
   border:1px groove;
   table-layout:fixed;
   margin:0 auto;
   border-collapse:collapse;
   }
   .test-story-main table tr{
   border:2px groove;
   
   }
   .test-story-main table th{
   border:2px groove;
   
   }
   .test-story-main table td{
   border:1px groove;
   
   }
   .test-story-main table thead{
   border:1px groove;
   background:#446BEC;
   text-align:center;
   }
   .test-story-main .separator{
   background:rgb(240, 240, 255);
   text-align:left;
   }
   .test-story-main table tbody tr td{
   text-align:left
   }
   .test-story-main .noData{
   background:#B8B8B8;
   }
   .test-story-main .childField{
   background:#B8B8B8;
   }
   .test-story-main .title{
   text-align:left;
   }
   .test-story-main h3{
   text-align:center;
   page-break-inside:avoid;
   }
   .test-story-main h2{
   text-align:center;
   }
   .test-story-main h1{
   text-align:center;
   }
   .test-story-main .pgBrk{
   padding-top:15px;
   }
   .test-story-main .er7Msg{
   width:100%;
   }
   .test-story-main .embSpace{
   padding-left:15px;
   }
   .test-story-main .accordion-heading{
   font-weight:bold;
   font-size:90%;
   }
   .test-story-main .accordion-heading i.fa:after{
   content:"\00a0 ";
   }
   .test-story-main panel{
   margin:10px 5px 5px 5px;
   }
   }
   
   @media print{
   .test-story-main legend{
   text-align:center;
   font-size:110%;
   font-weight:bold;
   }
   .test-story-main .nav-tabs{
   font-weight:bold;
   }
   .test-story-main .obxGrpSpl{
   background:#B8B8B8;
   }
   .test-story-main maskByMediaType{
   display:table;
   }
   .test-story-main table tbody tr th{
   font-size:90%
   }
   .test-story-main table tbody tr td{
   font-size:90%;
   }
   .test-story-main table tbody tr th{
   text-align:left;
   background:#C6DEFF;
   
   }
   .test-story-main table thead tr th{
   text-align:center;
   background:#4682B4;
   
   }
   .test-story-main fieldset{
   text-align:center;
   page-break-inside:avoid;
   }
   .test-story-main table{
   width:98%;
   border:1px groove;
   table-layout:fixed;
   margin:0 auto;
   page-break-inside:avoid;
   border-collapse:collapse;
   }
   .test-story-main table tr{
   border:2px groove;
   }
   .test-story-main table th{
   border:2px groove;
   }
   .test-story-main table td{
   border:1px groove;
   }
   .test-story-main table thead{
   border:1px groove;
   background:#446BEC;
   text-align:left;
   }
   .test-story-main .separator{
   background:rgb(240, 240, 255);
   text-align:left;
   }
   .test-story-main table tbody tr td{
   text-align:left;
   }
   .test-story-main .noData{
   background:#B8B8B8;
   }
   .test-story-main .childField{
   background:#B8B8B8;
   }
   .test-story-main .tds_title{
   text-align:left;
   margin-bottom:1%
   }
   .test-story-main h3{
   text-align:center;
   }
   .test-story-main h2{
   text-align:center;
   }
   .test-story-main h1{
   text-align:center;
   }
   .test-story-main .tds_pgBrk{
   page-break-after:always;
   }
   .test-story-main #er7Message table{
   border:0px;
   width:80%
   }
   .test-story-main #er7Message td{
   background:#B8B8B8;
   font-size:65%;
   margin-top:6.0pt;
   border:0px;
   text-wrap:preserve-breaks;
   white-space:pre;
   }
   .test-story-main .er7Msg{
   width:100%;
   font-size:80%;
   }
   .test-story-main .er7MsgNote{
   width:100%;
   font-style:italic;
   font-size:80%;
   }
   .test-story-main .embSpace{
   padding-left:15px;
   }
   .test-story-main .embSubSpace{
   padding-left:25px;
   }
   .test-story-main .accordion-heading{
   font-weight:bold;
   font-size:90%;
   }
   .test-story-main .accordion-heading i.fa:after{
   content:"\00a0 ";
   }
   .test-story-main panel{
   margin:10px 5px 5px 5px;
   }
   }
</style>
<!-- generated by TestStory_v1.xslt Version:1.0   Profile:TestStory-->
<fieldset>
	<div class="test-story-main">
		<tabset>
			<tab heading="FULL"  vertical="false">
				<div class="panel-body">
					<div class="panel-body"><table><tr><th>Description</th></tr><tr><td><p>An 18-year-old, Wray Charles Paige, visits a medical center in Pennsylvania on 1/23/2021 for a COVID-19 vaccine. A medical center staff member collects basic patient demographic information including name, date of birth, and sex. A medical center provider, Harry Porter (physician ID 954), reviews the patient&#39;s vaccination history with the patient. The patient identifies as Native American, and after reading the EUA patient factsheet for the Pfizer vaccine, which replaces the Vaccine Information Sheet (VIS), he decides not to receive the COVID-19 vaccine. A clinician, Janet Prince (ID 7282), enters the data into the sending application and transmits it to the IIS.</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Comments</th></tr><tr><td><p>The dates used in the test story and test messages are examples and can be changed to reflect appropriate current dates.</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Pre-condition</th></tr><tr><td><p>Sending systems should have the capability of sending an HL7 v2.5.1 standard-based Immunization Message Z22 Profile-VXU Message.</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Post-Condition</th></tr><tr><td><p>No PostCondition</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Test Objectives</th></tr><tr><td><p>This test case assesses the ability of the sending application:</p><ul><li>To create a vaccine administration message for an adult who refused a COVID-19 vaccine.</li><li>To support multiple birth indicator.</li></ul><p><br></p><p><br></p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Evaluation Criteria</th></tr><tr><td><p>Message Validation Report</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Notes</th></tr><tr><td><p>If known, the specific CVX code for the COVID-19 vaccine that is refused should be used, but CVX 213 &ldquo;SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED&rdquo; may be used to indicate that a patient refused a COVID-19 vaccine.</p><p>COVID-19 vaccines have received Emergency Use Authorization (EUA) by the FDA. Per the CDC, the VIS code set is being used to provide the EUA Recipient/Caregiver Fact Sheet codes for EHRs/EMRs for use in a manner analogous to the electronic system and workflow documentation of VIS. These codes were developed in advance of potential EUA decision by FDA for each vaccine.</p><p><br></p></td></tr></table></div><br/>
				</div>
			</tab>
			<tab heading="Description" vertical="false"><div class="panel-body"><table><tr><th>Description</th></tr><tr><td><p>An 18-year-old, Wray Charles Paige, visits a medical center in Pennsylvania on 1/23/2021 for a COVID-19 vaccine. A medical center staff member collects basic patient demographic information including name, date of birth, and sex. A medical center provider, Harry Porter (physician ID 954), reviews the patient&#39;s vaccination history with the patient. The patient identifies as Native American, and after reading the EUA patient factsheet for the Pfizer vaccine, which replaces the Vaccine Information Sheet (VIS), he decides not to receive the COVID-19 vaccine. A clinician, Janet Prince (ID 7282), enters the data into the sending application and transmits it to the IIS.</p></td></tr></table></div></tab><tab heading="Comments" vertical="false"><div class="panel-body"><table><tr><th>Comments</th></tr><tr><td><p>The dates used in the test story and test messages are examples and can be changed to reflect appropriate current dates.</p></td></tr></table></div></tab><tab heading="Pre-condition" vertical="false"><div class="panel-body"><table><tr><th>Pre-condition</th></tr><tr><td><p>Sending systems should have the capability of sending an HL7 v2.5.1 standard-based Immunization Message Z22 Profile-VXU Message.</p></td></tr></table></div></tab><tab heading="Post-Condition" vertical="false"><div class="panel-body"><table><tr><th>Post-Condition</th></tr><tr><td><p>No PostCondition</p></td></tr></table></div></tab><tab heading="Test Objectives" vertical="false"><div class="panel-body"><table><tr><th>Test Objectives</th></tr><tr><td><p>This test case assesses the ability of the sending application:</p><ul><li>To create a vaccine administration message for an adult who refused a COVID-19 vaccine.</li><li>To support multiple birth indicator.</li></ul><p><br></p><p><br></p></td></tr></table></div></tab><tab heading="Evaluation Criteria" vertical="false"><div class="panel-body"><table><tr><th>Evaluation Criteria</th></tr><tr><td><p>Message Validation Report</p></td></tr></table></div></tab><tab heading="Notes" vertical="false"><div class="panel-body"><table><tr><th>Notes</th></tr><tr><td><p>If known, the specific CVX code for the COVID-19 vaccine that is refused should be used, but CVX 213 &ldquo;SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED&rdquo; may be used to indicate that a patient refused a COVID-19 vaccine.</p><p>COVID-19 vaccines have received Emergency Use Authorization (EUA) by the FDA. Per the CDC, the VIS code set is being used to provide the EUA Recipient/Caregiver Fact Sheet codes for EHRs/EMRs for use in a manner analogous to the electronic system and workflow documentation of VIS. These codes were developed in advance of potential EUA decision by FDA for each vaccine.</p><p><br></p></td></tr></table></div></tab>
		</tabset>
	</div>
</fieldset>